Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More

Print Email

Stocks were staging a recovery on Tuesday and investors are again looking for upside and sectors where they feel safe. 24/7 Wall St. reviews dozens of analyst research reports each morning to find new investment and trading ideas for our readers. Some of the daily analyst reports cover stocks to buy, and some of them feature stocks to sell or to avoid.

These are this Tuesday’s top analyst upgrades, downgrades and initiations from Wall Street firms.

Allergan Inc. (NYSE: AGN) was raised to Buy from Neutral at UBS — the deal hope and talk continues.

Amazon.com Inc. (NASDAQ: AMZN) is due to report earnings in just two days, yet the online seller of everything was downgraded to Neutral from Buy at Citigroup.

American Axle & Manufacturing Holdings Inc. (NYSE: AXL) was raised to Neutral from Underweight at J.P. Morgan.

Arcos Dorados Holdings Inc. (NYSE: ARCO) was downgraded to Underweight from Neutral at HSBC.

Celestica Inc. (NYSE: CLS) was downgraded to Sector Underperform from Sector Perform at Scotia.

ALSO READ: 10 Brands That Will Disappear in 2015

Chipotle Mexican Grill (NYSE: CMG) rose after earnings and targets are being raised, with shares indicated up about 10% at $650. RBC raised its target to $730 from $680, Piper Jaffray to $740 from $610 and Baird to $800 from $650. Estimates were raised at Sterne Agee with a $742 price target.